On October 29, 1959, the pharmaceutical company G.D. Searle filed an application with the U.S. Food and Drug Administration ... of the barracks-like wooden building for an hour and a half.

Orphan drug status, a status designated by the Food and Drug Administration (FDA), gives companies researching cures for rare diseases a seven-year window of exclusive marketing rights post ...